The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 762 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 18.21

Myeloma (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2012
By Race/Ethnicity, Sex and Years Since Diagnosis
Race/Ethnicity Sex Years Since Diagnosis Completeh
0 to <5 5 to <10 10 to <15 15 to <20 20 to <25 25 to <30 0 to <20e 0 to <37e >=37g
All Races b Both Sexes 56,508 20,540 7,352 3,082 1,394 365 88,267 89,416 242 89,658
Males 30,245 11,069 4,053 1,603 754 192 47,394 47,990 84 48,074
Females 26,263 9,471 3,299 1,479 640 173 40,873 41,426 158 41,584
White b Both Sexes 41,956 15,946 5,693 2,401 1,044 304 66,608 67,438 0 67,438
Males 23,218 8,979 3,361 1,246 569 174 37,140 37,583 0i 37,583
Females 18,738 6,967 2,332 1,155 475 130 29,468 29,855 0i 29,855
Black b Both Sexes 11,675 3,969 1,304 564 294 41 17,660 17,922 + +
Males 5,512 1,791 508 302 173 13 8,189 8,338 + +
Females 6,163 2,178 796 262 121 28 9,471 9,584 + +
Asian/
Pacific
Islander c
Both Sexes 1,548 395 208 + + + 2,231 + + +
Males 824 196 101 + + + 1,158 + + +
Females 724 199 107 + + + 1,073 + + +
Hispanic d Both Sexes 4,223 1,366 618 + + + 6,386 + + +
Males 2,296 749 340 + + + 3,488 + + +
Females 1,927 617 278 + + + 2,898 + + +
Estimated prevalence percent a on January 1, 2012, of the SEERc population diagnosed in the previous 20 years
By Age at Prevalence, Race/Ethnicity and Sex
Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedf
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races c Both Sexes 0.0250% - - 0.0004% 0.0022% 0.0117% 0.0358% 0.0839% 0.1306% 0.1122% 0.0238%
Males 0.0274% - - 0.0006% 0.0027% 0.0138% 0.0401% 0.0999% 0.1538% 0.1425% 0.0283%
Females 0.0227% - - - 0.0017% 0.0096% 0.0317% 0.0695% 0.1119% 0.0942% 0.0202%
White c Both Sexes 0.0245% - - 0.0005% 0.0022% 0.0104% 0.0326% 0.0782% 0.1232% 0.1054% 0.0222%
Males 0.0276% - - 0.0007% 0.0027% 0.0129% 0.0370% 0.0955% 0.1487% 0.1408% 0.0271%
Females 0.0214% - - - 0.0018% 0.0078% 0.0282% 0.0619% 0.1021% 0.0843% 0.0181%
Black c Both Sexes 0.0401% - - - 0.0034% 0.0277% 0.0729% 0.1754% 0.2486% 0.2201% 0.0481%
Males 0.0394% - - - 0.0041% 0.0277% 0.0756% 0.2014% 0.2796% 0.2221% 0.0524%
Females 0.0407% - - - 0.0028% 0.0277% 0.0707% 0.1549% 0.2269% 0.2191% 0.0449%
Asian/
Pacific
Islander c
Both Sexes 0.0147% - - - 0.0009% 0.0054% 0.0207% 0.0471% 0.0877% 0.0815% 0.0147%
Males 0.0157% - - - 0.0014% 0.0072% 0.0246% 0.0521% 0.0996% 0.0988% 0.0172%
Females 0.0137% - - - - 0.0038% 0.0174% 0.0429% 0.0786% 0.0710% 0.0127%
Hispanic d Both Sexes 0.0125% - - 0.0006% 0.0023% 0.0095% 0.0327% 0.0663% 0.1233% 0.0977% 0.0211%
Males 0.0134% - - 0.0010% 0.0029% 0.0121% 0.0385% 0.0806% 0.1312% 0.1226% 0.0247%
Females 0.0116% - - - 0.0016% 0.0069% 0.0272% 0.0540% 0.1175% 0.0828% 0.0181%

Footnotes:

a US 2012 cancer prevalence counts are based on 2012 cancer prevalence proportions from the SEER registries and 1/1/2012 US population estimates based on the average of 2011 and 2012 population estimates from the US Bureau of the Census. Prevalence was calculated using the First Malignant Primary Only for a person.

b Statistics based on SEER 9 Areas.

c Statistics based on SEER 11 Areas and Rural Georgia

d Statistics based on NHIA for Hispanic for SEER 11 Areas and Rural Georgia.

e Maximum limited-duration prevalence: 37 years for 1975-2012 SEER 9 data; 20 years for 1992-2012 SEER 11 data (used to calculate prevalence for Hispanics and Asian Pacific Islanders).

f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

g Cases diagnosed more than 37 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

h Complete prevalence is obtained by summing 0 to <37 and >=37.

i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.